These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1444 related items for PubMed ID: 17242396
1. Revised response criteria for malignant lymphoma. Cheson BD, Pfistner B, Juweid ME, Gascoyne RD, Specht L, Horning SJ, Coiffier B, Fisher RI, Hagenbeek A, Zucca E, Rosen ST, Stroobants S, Lister TA, Hoppe RT, Dreyling M, Tobinai K, Vose JM, Connors JM, Federico M, Diehl V, International Harmonization Project on Lymphoma. J Clin Oncol; 2007 Feb 10; 25(5):579-86. PubMed ID: 17242396 [Abstract] [Full Text] [Related]
3. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. Cheson BD, Fisher RI, Barrington SF, Cavalli F, Schwartz LH, Zucca E, Lister TA, Alliance, Australasian Leukaemia and Lymphoma Group, Eastern Cooperative Oncology Group, European Mantle Cell Lymphoma Consortium, Italian Lymphoma Foundation, European Organisation for Research, Treatment of Cancer/Dutch Hemato-Oncology Group, Grupo Español de Médula Ósea, German High-Grade Lymphoma Study Group, German Hodgkin's Study Group, Japanese Lymphorra Study Group, Lymphoma Study Association, NCIC Clinical Trials Group, Nordic Lymphoma Study Group, Southwest Oncology Group, United Kingdom National Cancer Research Institute. J Clin Oncol; 2014 Sep 20; 32(27):3059-68. PubMed ID: 25113753 [Abstract] [Full Text] [Related]
4. Expert opinions on positron emission tomography and computed tomography imaging in lymphoma. Delbeke D, Stroobants S, de Kerviler E, Gisselbrecht C, Meignan M, Conti PS. Oncologist; 2009 Sep 20; 14 Suppl 2():30-40. PubMed ID: 19819922 [Abstract] [Full Text] [Related]
8. 18F-FDG PET as a routine test for posttherapy assessment of Hodgkin's disease and aggressive non-Hodgkin's lymphoma: where is the evidence? Juweid ME. J Nucl Med; 2008 Jan 20; 49(1):9-12. PubMed ID: 18077522 [No Abstract] [Full Text] [Related]
9. The use of interim (18)F-fluorodeoxyglucose PET to guide therapy in lymphoma. Araf S, Montoto S. Future Oncol; 2013 Jun 20; 9(6):807-15. PubMed ID: 23718301 [Abstract] [Full Text] [Related]
10. Hodgkin's and non-Hodgkin's lymphomas. Rademaker J. Radiol Clin North Am; 2007 Jan 20; 45(1):69-83. PubMed ID: 17157624 [Abstract] [Full Text] [Related]
12. The use of positron emission tomography with [18F] 2-fluoro-D-2-deoxyglucose (FDG-PET) in Hodgkin and non-Hodgkin's lymphoma. Chiusolo P, Sica S, Leone G. Hematology; 2003 Dec 20; 8(6):403-8. PubMed ID: 14668036 [Abstract] [Full Text] [Related]
14. Fluorine-18 fluorodeoxyglucose PET/CT patterns of extranodal involvement in patients with Non-Hodgkin lymphoma and Hodgkin's disease. Even-Sapir E, Lievshitz G, Perry C, Herishanu Y, Lerman H, Metser U. Radiol Clin North Am; 2007 Jul 20; 45(4):697-709, vii. PubMed ID: 17706534 [Abstract] [Full Text] [Related]